One of the more popular sessions at the Academy of Managed Care Pharmacy 24th Annual Meeting on Thursday featured Paul Frostin, PhD, Director, Health Research and Education Program, Employee Benefit Research Institute, on the topic of health insurance exchanges.
One of the more popular sessions at the Academy of Managed Care Pharmacy 24th Annual Meeting on Thursday featured Paul Frostin, PhD, Director, Health Research and Education Program, Employee Benefit Research Institute. Frostin’s presentation, “Essential Benefits and Exchanges Update for Managed Care Pharmacy,” identified highlights of the of the Exchanges final ruling and talked about how these changes would impact managed care pharmacy. In particular, Frostin mentioned that the final rule would allow states to go beyond minimum standards. States would also be able to charge fees to carriers to cover cost of operating exchanges. As far as transparency, exchange carriers would need to provide enrollees with an enrollment package and include information on hot to access the provider directory and drug formulary.
Notable Dates
Assuming that the Supreme Court proclaims these exchanges constitutional, states that have failed to establish an exchange in the shortened timeline will have few legislative options remaining. If a state fails to establish an exchange, a federally facilitated exchange will be implemented. Following the initial setup, here are the timelines going forward:
But before a final rule can be made, there may need to be some clarification from HHS, such as comments on interim rules related to definitions of pharmacy benefit management, generic drugs, rebates, discounts, etc. Frostin also mentioned that, when definitional issues come into question, definitions will be aligned with the Medicare program to the extent possible. Essential health benefits per the Affordable Care Act include the following:
For more information about this presentation, please visit www.amcp.org.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More